Age-Specific Seroprevalence of Human Parvovirus B19 in Thailand: A Cross-Sectional Study Across Four Geographic Regions with Global Comparison.
- 1Department of Pediatrics, Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
- 2The Royal Society of Thailand, Sanam Sueapa, Bangkok 10300, Thailand.
Abstract
Human parvovirus B19 (B19V) usually causes self-limiting infection but can cause severe complications in pregnancy, chronic hemolytic disease, and immunocompromise. Contemporary data on B19V immunity in Southeast Asia remain limited. We conducted an age-stratified, cross-sectional serosurvey of 430 residual specimens from four Thai provinces (April to August 2024) and compared findings against published age-specific data from 13 countries. Anti-B19V IgG was measured by quantitative ELISA, with seropositivity defined as 5.5 IU/mL or higher. Overall, 87 of 430 participants (20.2%; 95% CI, 16.5 to 24.3%) were seropositive, with a non-monotonic age pattern: 31.7% among children aged 0 to 5, falling to 4.7% at 6 to 12 years, then rising to 51.2% among those 60 and older. A serocatalytic model estimated an average constant force of infection of 8.5 per 1000 person-years beyond age 6; the present data did not provide evidence for the concentrated school-age transmission peak reported in Japan and Europe. From school age onward, Thai seroprevalence was toward the lower end of published estimates, a pattern shared with other Southeast and East Asian settings, although differences in assays, sampling frames, and study periods limit direct comparison. Seroprevalence was similarly elevated among children aged 1 to 2 and 3 to 5 years, and was therefore not concentrated in infancy; most seropositive young children had IgG concentrations close to the assay cut-off, and the explanation for this pattern remains uncertain. No significant differences by sex or province were observed. These findings suggest that a substantial proportion of adolescents and adults in the populations sampled lack detectable anti-B19V IgG and may remain susceptible to infection.
Related
- Seroprevalence of Japanese encephalitis virus and other flavivirus-specific antibodies among Australian blood donors following a novel epidemic spread of Japanese encephalitis virus: a cross-sectional study
- Seroprevalence of measles-specific IgM and IgG antibodies among children (0–12 years) with measles-like symptoms: a hospital-based cross-sectional study in Northeast Nigeria
- HBV exposure, HBsAg positivity, and anti-HDV seroprevalence in rural communities along the Iran–Afghanistan border: a community-based cross-sectional study
- Geographic variation in proportions meeting the waist circumference criterion and having elevated hemoglobin A1c among Specific Health Checkup examinees in Japan: an ecological analysis of the 10th NDB Open Data
- Seroprevalence and awareness of hepatitis C infection among informal workers at Kejetia Market, Ghana: A cross-sectional study
BibTeX
@article{nilyanimit2026agespecific,
title = {{Age-Specific Seroprevalence of Human Parvovirus B19 in Thailand: A Cross-Sectional Study Across Four Geographic Regions with Global Comparison.}},
author = {Pornjarim Nilyanimit and Jiratchaya Puenpa and Nungruthai Suntronwong and Sirapa Klinfueng and Ritthideach Yorsaeng and Thananrat Thongmee and Yong Poovorawan},
journal = {Tropical medicine and infectious disease},
year = {2026},
month = oct,
doi = {10.3390/tropicalmed11100291},
url = {https://europepmc.org/article/MED/42931476},
note = {CC BY},
}
RIS
TY - JOUR
TI - Age-Specific Seroprevalence of Human Parvovirus B19 in Thailand: A Cross-Sectional Study Across Four Geographic Regions with Global Comparison.
AU - Pornjarim Nilyanimit
AU - Jiratchaya Puenpa
AU - Nungruthai Suntronwong
AU - Sirapa Klinfueng
AU - Ritthideach Yorsaeng
AU - Thananrat Thongmee
AU - Yong Poovorawan
PY - 2026
DA - 2026/10/13
JO - Tropical medicine and infectious disease
DO - 10.3390/tropicalmed11100291
UR - https://europepmc.org/article/MED/42931476
AB - Human parvovirus B19 (B19V) usually causes self-limiting infection but can cause severe complications in pregnancy, chronic hemolytic disease, and immunocompromise. Contemporary data on B19V immunity in Southeast Asia remain limited. We conducted an age-stratified, cross-sectional serosurvey of 430 residual specimens from four Thai provinces (April to August 2024) and compared findings against published age-specific data from 13 countries. Anti-B19V IgG was measured by quantitative ELISA, with seropositivity defined as 5.5 IU/mL or higher. Overall, 87 of 430 participants (20.2%; 95% CI, 16.5 to 24.3%) were seropositive, with a non-monotonic age pattern: 31.7% among children aged 0 to 5, falling to 4.7% at 6 to 12 years, then rising to 51.2% among those 60 and older. A serocatalytic model estimated an average constant force of infection of 8.5 per 1000 person-years beyond age 6; the present data did not provide evidence for the concentrated school-age transmission peak reported in Japan and Europe. From school age onward, Thai seroprevalence was toward the lower end of published estimates, a pattern shared with other Southeast and East Asian settings, although differences in assays, sampling frames, and study periods limit direct comparison. Seroprevalence was similarly elevated among children aged 1 to 2 and 3 to 5 years, and was therefore not concentrated in infancy; most seropositive young children had IgG concentrations close to the assay cut-off, and the explanation for this pattern remains uncertain. No significant differences by sex or province were observed. These findings suggest that a substantial proportion of adolescents and adults in the populations sampled lack detectable anti-B19V IgG and may remain susceptible to infection.
SN - 2414-6366
ER -